Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101575298B details a cost-effective synthesis of chiral 2-amino-1-phenylethylalcohol from styrene glycol, offering high optical purity for beta-agonist manufacturing.
Discover the patented CN102134252B process for synthesizing >99% pure cefuroxime acid. Learn how ternary solvent extraction reduces lactone impurities and ensures supply chain stability.
Patent CN104630241A enables high-purity statin intermediate production with reduced waste and enhanced supply chain reliability for global pharmaceutical manufacturing partners seeking cost efficiency.
Patent CN104163806A reveals high-purity triacetylglucal method. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113135991A reveals a fragment condensation method reducing D-His impurities. Enhances purity and yield for scalable GLP-1 manufacturing.
Patent CN107827844A details a cost-effective synthesis route for butyrolactone derivatives. This method offers significant supply chain advantages and high purity for pharmaceutical manufacturing.
Patent CN114276369B details a novel synthesis of anti-tuberculosis indoloquinolines from rufloxacin, offering improved solubility and resistance profiles for pharmaceutical manufacturing.
Patent CN111051506A discloses engineered PGA variants for efficient insulin dimer deprotection. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Advanced solvent-free purification of Mupirocin via macroporous resin and nanofiltration. Achieves >99% purity with reduced costs and enhanced supply chain safety.
Patent CN112479938A reveals a novel one-pot synthesis for CHES buffer using commodity raw materials, offering >99% purity and significant cost reduction for pharmaceutical manufacturing.
Novel oxalic acid pH adjustment method for high-purity fusidic acid. Reduces solvent waste and improves yield for antibiotic manufacturing supply chains.
Patent CN109609475A reveals mutant dehydrogenase for high-purity L-Glufosinate-ammonium. Offers scalable agrochemical intermediate manufacturing with reduced waste.
Novel thalidomide-based PROTACs for fibrosis and cancer. Efficient solid-phase synthesis ensures high purity and scalable supply chain solutions.
Patent CN1042705A reveals a streamlined route for pyridine intermediates, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel process for 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl)-N,N-dimethylacetamide reduces urea byproducts and enhances yield for ARB manufacturing.
Novel synthetic route for Cefmetazole Sodium offering high purity and yield. Optimized for cost-effective cephalosporin manufacturing and scalable supply chain solutions.
Patent CN117417285B reveals metal-free route for Evocalcet intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally
Novel patent CN119060034A offers high-yield morpholine synthesis without chiral resolution ensuring cost-effective and reliable supply chain solutions for global pharmaceutical manufacturers.
Patent CN10506141416A reveals high-yield flumioxazin synthesis. Reduces impurities significantly. Ideal for agrochemical supply chains seeking cost-effective manufacturing.
Novel preparation method for Ceforanide antibiotic intermediates featuring mild conditions, improved yield, and reduced environmental impact for global supply chains.